Immunodiagnostics Industry Outlook 2025-2029: Market Set to Cross $32.89 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Immunodiagnostics Market Size By 2025?
The size of the immunodiagnostics market has seen significant expansion in the past few years. The market is projected to expand from $22.88 billion in 2024 to $24.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The historic growth is due to multiple factors including a spike in infectious diseases, an increase in autoimmune diseases, cancer detection and surveillance, the global spread of infectious diseases, public health efforts, and various screening programs.

How Big Is the Immunodiagnostics Market Size Expected to Grow by 2029?
The immunodiagnostics market is anticipated to experience robust expansion in the coming years. By 2029, the market is projected to reach $32.89 billion, affirming a compound annual growth rate (CAGR) of 7.8%. The escalation projected within this period is credited to factors such as preparedness and reaction to pandemics, the development and implementation of personalized medicine and biomarker discovery, the evolution of healare infrastructure in developing markets, compatibility with laboratory information systems, and the increasing prevalence of chronic diseases. Emerging trends predicted for the forecast period encompass multiplexing technologies, point-of-care testing (POCT), advancements in biomarker discovery and personalized medicine, the advent of digital immunodiagnostics, and a shift towards liquid biopsy.

View the full report here:
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Which Key Market Drivers Powering Immunodiagnostics Market Expansion and Growth?
The escalating occurrence of infectious diseases is predicted to propel the growth of the immunodiagnostics market in the future. Such diseases can be spread from person to person and are generally caused by viruses, bacteria, fungi, or parasites. An immunodiagnostic assay is a significant tool used in the identification of a virus in a blood sample. For example, in March 2024, data from the Centers for Disease Control and Prevention, a governmental agency in the US, showed that there was a rise in tuberculosis cases from 8,320 in 2022 up to 9,615 in 2023, indicating an increase of 1,295 cases. Therefore, the rise in infectious diseases is anticipated to spur on the immunodiagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Immunodiagnostics Market?
Leading enterprises in the immunodiagnostics market are concentrating their efforts on creating innovative solutions such as the S. pneumoniae Antigen Immunodiagnostic Assay for the identification of pneumococcal pneumonia infection. The particular assay serves to identify the presence of Streptococcus pneumoniae antigens within bodily fluids, which assists in diagnosing pneumococcal infections. For example, in September 2024, the biotechnology firm based in Italy, DiaSorin S.p.A. introduced the LIAISON S. pneumoniae antigen immunodiagnostic assay in the market. This diagnostic test, developed for the qualitative detection of Streptococcus pneumoniae antigens in adult urine samples suspected of pneumococcal pneumonia, provides a high-throughput solution enabling healare professionals to swiftly diagnose and differentiate between pneumococcal pneumonia and other respiratory infections. Utilizing LIAISON CLIA analyzers, test results are generated in as little as 35 minutes, enabling speedy and precise antimicrobial treatment. Furthermore, its capability to detect 91 serotypes bolsters clinical decision-making and promotes effective antibiotic stewardship. This marks a significant breakthrough in the field of immunodiagnostics for community-caught pneumonia.

What Are the Emerging Segments in the Immunodiagnostics Market?
The immunodiagnostics market covered in this report is segmented -

1) By Product: Reagents And Consumables, Instruments, Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:
1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Who Are the Global Leaders in the Immunodiagnostics Market?
Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton inson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

Which are the Top Profitable Regional Markets for the Immunodiagnostics Industry?
North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10093

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.